Applications published 15 August 2007

Stabilised HME compsn with small drug particles
Board of Regents, the University of Texas System 1817008*

Orally disintegrating compsns
Spi Pharma 1817009*

Controlled absorption of statins in the intestine
Dexcel Pharma Technologies 1817010*

Methods and compsns for deterring abuse of orally administered pharmaceutical products
Acura Pharmaceuticals 1817011*

Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
Merck 1817012*

Enteric coated bead comprising ixabepilone and preparation thereof
Bristol-Myers Squibb 1817013*

Method of providing fast relief to a user of nicotine chewing gum
Fertin Pharma 1817014*

Pharmaceutical formulations
Vectura 1817015*

Method for maximising efficacy and predicting and minimising toxicity of calcineurin inhibitor compounds
Isotechnika International 1817016*

Antioxidant dietary supplement compsns and methods for maintaining healthy skin
Chomczynski, Piotr 1817017*

Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants
MediQuest Therapeutics 1817018*

Therapeutic formulations
Myriad Genetics 1817019*

Histone deacetylase inhibitors
Errant Gene Therapeutics 1817020*

NSAID compsns exhibiting clinical superiority
Equitech Corp 1817021*

Methods for increasing the immune response in an animal
Hill's Pet Nutrition 1817022*

Methods and compsns for treating pain
Limerick Neurosciences 1817023*

Andrographolide derivatives to treat viral infections
Cornell Research Foundation 1817024*

Tetrahydroxycarbazoles as active agents for inhibiting VEGF production by translational control
PTC Therapeutics 1817025*

HCV inhibitors
SmithKline Beecham Corp 1817026*

Process for preparing enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof
Ranbaxy Laboratories 1817027*

Antimitotic anti-proliferative compounds
University of Medicine and Dentistry of New Jersey 1817028*

Isoxazolic derivative to relieve neuropathic pain
Zambon 1817029*

Inducible nitric oxide synthase dimerisation inhibitors
Kalypsys 1817030*

Novel specific caspase-10 inhibitors
Merck Patent 1817031*

Modulators of muscarinic receptors
Vertex Pharmaceuticals 1818032*

Treatment of inflammatory bowel disease
Allergan 1817033*

M1 and/or M3 receptor antagonists in combination with other actives for treating respiratory disorders
Schering 1817034*

Solid formulations of liquid biologically active agents
Labopharm; Labopharm Europe; Labopharm (Barbados) 1817035*

Modulators of muscarinic receptors
Vertex Pharmaceuticals 1817036*

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
Abbott 1817037*

Combination comprising ZD6474 and an antiandrogen
AstraZeneca 1817038*

Treatment and prevention of epilepsy
University of Rochester 1817039*

Enhancer of the effect of adrenocorticoid, comprising gum arabic
Veritron 1817040*

TAFI inhibitors and their use to treat pulmonary fibrosis
Bayer Schering; Mie University 1817041*

Glycerin based synthesis of silver nanoparticles and nanowires
Board of Regents, The University of Texas System 1817042*

Encapsulated bacteriophage formulation
Gangagen Life Sciences 1817043*

Compsn comprising a polysaccharide with bacteria blocking action
Passion for Life Healthcare 1817044*

Novel antimicrobial peptides
Dermagen 1817046*

Use of SCF and G-CSF in the treatment of cerebral ischaemia and neurological disorders
Northwestern University 1817047*

Stable formulations of insulinoptropic peptides
Novo Nordisk 1817048*

Soluble, stable insulin-containing formulations with a protamine salt
Novo Nordisk 1817049*

Diagnosis and treatment of Alzheimer's disease
Rhode Island Hospital 1817050*

Pharmaceutical compsns comprising botulinum neurotoxin, a non-ionic surfactant, sodium chloride and sucrose
Ipsen 1817051*

Compsn and methods for the treatment of autism
Kirkman Group 1817052*

Novel pharmaceutical compsn useful for vaccines
Vetoquinol 1817053*

Naturally occurring IGM antibodies that bind lymphocytes
Lobo, Peter 1817054*

OVR110 antibody compsns and methods of use
Diadexus 1817055*

Parathyroid hormone receptor activation and stem and progenitor cell expansion
The General Hospital Corp 1817056*

PTPase inhibitors and T-cell activators for treating cancer
The Cleveland Clinic Foundation 1817057*

Methods for improving liver clearance of xenobiotic substances in an animal
Hill's Pet Nutrition 1817058*

Conjugates of 1,8-bis-naphthalimides with an antibody
Genentech 1817059*

MDA-7 protein variants having antiproliferative activity
The Trustees of Columbia University in the City of New York 1817060*

Electroporation of mycobacterium and overexpression of antigens in mycobacteria
Aeras Global Tuberculosis Vaccine Foundation 1817061*

Radiation disometry and blocking antibodies and methods and uses therefor in the treatment of cancer
Duke University 1817062*

Device for irradiating liquids with UV radiation in an throughflow
Delta UV Service Systeme 1817063*